about
Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteersDesign, synthesis and properties of novel powerful antioxidants, glutathione analogues.Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacinMale infertility workup needs additional testing of expressed prostatic secretion and/or post-massage urineThe use of probiotic L. fermentum ME-3 containing Reg'Activ Cholesterol supplement for 4 weeks has a positive influence on blood lipoprotein profiles and inflammatory cytokines: an open-label preliminary study.Immunological, antioxidative, and morphological response in combined treatment of ofloxacin and Lactobacillus fermentum ME-3 probiotic in Salmonella Typhimurium murine model.Are prostatitis symptoms associated with an isoprostane-mediated vicious circle?Two antioxidative lactobacilli strains as promising probiotics.Oxidative stress before and after exercise conditioning in patients following surgical revascularization of the myocardium.Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects.Nickel sulphate and epoxy resin: differences in iron status and glutathione redox ration at the time of patch testing.Allergic contact dermatitis is accompanied by severe abnormal changes in antioxidativity of blood.Ferrous iron administration during pregnancy and adaptational oxidative stress (Pilot study).Male infertility: decreased levels of selenium, zinc and antioxidants.Oxidative stress in patients with endodontic pathologies.Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension.Oxidative stress in patients with endodontic pathologies.Inflammation and oxidative stress are associated differently with endothelial function and arterial stiffness in healthy subjects and in patients with atherosclerosis.Fermented whey-based product improves the quality of life of males with moderate lower urinary tract symptoms: A randomized double-blind study.
P50
Q24810974-C5F7F6AB-F13E-40DC-A6B7-11B06AB565AFQ33288138-8AF24556-7908-40DD-B7C1-4185B78ED63DQ33357682-2DA61B66-57D5-4085-9DE9-09E2BBDE70B1Q35070507-60385F90-31D2-41E8-85FD-68B78A801B34Q37374367-F8F6A502-8311-46FF-8448-3AECE917F2F4Q40345955-68511D5C-D8A9-4B91-8553-18500625AE35Q43850434-77513800-0A48-42D8-94A4-F956B54AF269Q43886837-D81FEDED-1085-4529-882C-079AB4ABFFDDQ44228706-C9B68553-CA5A-4CF8-942B-914B17CC19BEQ44543214-DDE02DC8-8650-46DF-AB83-D1C439DF6111Q44815218-6B665C1E-981F-4B8E-B947-5927156D4970Q44926709-6AA6A0CC-07F5-4552-B0D5-BC564BE9A654Q44945565-CDEAAAAB-A8C8-42FE-88A5-E716E4158382Q45742777-3C5A9CFB-23D0-4E0A-85AA-BEC0EE87A734Q47106450-CD910110-A963-4986-A63D-211986C2C104Q47609049-45444090-75CD-403C-B0B6-7EE145CCD365Q47819786-71F6EBBD-A3D2-4B0E-9DE8-0A0A380B5ECCQ47981020-5CE9183E-DC79-4969-BB20-90D172CFF861Q55002773-1791D002-CBFD-4C4C-B8B6-D14B5A13CC8A
P50
name
Tiiu Kullisaar
@ast
Tiiu Kullisaar
@en
Tiiu Kullisaar
@es
Tiiu Kullisaar
@nl
type
label
Tiiu Kullisaar
@ast
Tiiu Kullisaar
@en
Tiiu Kullisaar
@es
Tiiu Kullisaar
@nl
prefLabel
Tiiu Kullisaar
@ast
Tiiu Kullisaar
@en
Tiiu Kullisaar
@es
Tiiu Kullisaar
@nl
P21
P214
6795149544612400490000
P2953
Tiiu_Kullisaar
P31
P569
1947-02-20T00:00:00Z
P7859
viaf-6795149544612400490000